Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $0.04 by 1100 percent. This is a 300 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $608.104 million which missed the analyst consensus estimate of $616.853 million by 1.42 percent. This is a 3.77 percent increase over sales of $586.010 million the same period last year.